Establishing Muscle Impedance Parameters With Electrical Impedance Myography

Completed

Conditions studied: IBM, Inclusion Body Myositis

In brief

The primary aim of this study is to assess the changes in the impedance parameters of muscles in inclusion body myositis (IBM) through electrical impedance myography (EIM), an emerging non-invasive electrodiagnostic technology. Muscle impedance parameters can potentially serve as an objective biomarker reflecting disease progression and severity.

Key facts

Study ID

NCT03633318

Run by

Yale University

People needed

31

Starts

2018-06-19

Expected to finish

2019-06-30

Last updated by the study team

2020-08-11

Who can join

Age: 46 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Clinico-pathologically defined IBM in the absence of any other significant neurological problem or cognitive dysfunction.
• Healthy controls will be age and gender-matched to the enrolled IBM patients.
• Exclusion Criteria for both IBM and control group:
• Patients with decompensated congestive heart failure
• Patients with chronic kidney disease on hemodialysis
• Patients with active cancer on chemotherapy or radiotherapy
• Patients with severe disease who are already wheel-chair bound

Where it is running

• Yale Physicians Building — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.